Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria

Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria

US Patent 11116765 · Granted Sep 14, 2021

Estimated economic value: $12,813,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Concentrated, inhalable ciprofloxacin formulation2021
Concentrated, inhalable ciprofloxacin formulation2021
Compositions for topical application of a medicaments onto a mammalian body surf2020
Concentrated, inhalable ciprofloxacin formulation2019
Concentrated, inhalable ciprofloxacin formulation2019
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2019
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2019
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2019
Liposomal ciprofloxacin formulations with activity against non-tuberculous mycob2019
Inhaled surfactant-modified liposomal formulations providing both an immediate a2018
Inhaled surfactant-modified liposomal formulations providing both an immediate a2018
Liposomal formulations that form drug nanocrystals after freeze-thaw2018